Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study

At our VA hospital, in general, it is the policy of our GI lab to not stop our patients anti-platelet therapy whenever they see us for a routine colonoscopy. We do this because we believe the risk of stopping these sort of medications outweigh the risks of a complication from a colonoscopy.

Therefore, we are enrolling patients who are either on clopidogrel or prasugrel or not on any anti-platelet/anti-coagulant therapy that come to our GI lab routine colonoscopies. We perform the procedure just like we normally would and then follow-up with the patient 7 and 30 days after their procedure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post-polypectomy Bleeding Anti-platelet Therapy Colonoscopy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Dallas VA Medical Center

Dallas, Texas, 75216, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients presenting to the GI lab for elective colonoscopy

Exclusion criteria

Patients on Coumadin or other anti-coagulants
Patients with Inflammatory Bowel Disease

Sponsors and collaborators

Lead sponsor

Dallas VA Medical Center

Fed

Registry information

Important dates

Study start: 2009
Primary completion: 2012
First posted: Jul 23, 2012
Registry last updated: Jul 23, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed